Top compounds associated with response to SMYD1


Feature Type Standardized
Nominal ANOVA
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.0078 0.8
mRNA 681640 GDSC1000 pan-cancer AAC -0.0073 0.8
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0069 0.8
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.0063 0.8
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.007 0.9
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0065 0.9
mRNA DBeQ CTRPv2 pan-cancer AAC 0.0068 0.9
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.0071 0.9
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.0069 0.9
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.33 0.9
Download CSV